Us Congress 2023-2024 Regular Session

Us Congress House Bill HB6283

Introduced
11/8/23  
Refer
11/8/23  
Refer
11/10/23  

Caption

DRUG Act Delinking Revenue from Unfair Gouging Act

Impact

Should the bill be enacted, its impact would resonate through federal healthcare regulations, especially concerning contracts between PBMs and insurance carriers. The enforcement mechanisms established would empower federal agencies, including the Secretary of Health and Human Services, to impose civil penalties on PBMs that do not comply with the new rules. Additionally, any violations by PBMs would be subject to civil monetary penalties, aimed at fostering compliance and reducing possible abuses associated with the management of prescription drug benefits.

Summary

House Bill 6283, known as the Delinking Revenue from Unfair Gouging Act or the DRUG Act, aims to enhance the services provided by pharmacy benefit managers (PBMs) while addressing practices that may negatively impact patients and healthcare costs. The bill introduces regulations that prohibit PBMs from receiving remuneration for prescription drug-related services except through bona fide service fees set by agreement, which must be flat amounts and not contingent on prescription drug pricing or other variables. This approach is designed to improve transparency in the pricing of prescription drugs and associated healthcare services.

Contention

Notably, Bill HB6283 has sparked discussions around the balance of power between PBMs and pharmacies, particularly concerning practices such as 'steering'. The bill ensures that PBMs cannot unfairly promote pharmacies that they own or are affiliated with, thereby encouraging more competitive practices while mitigating potential conflicts of interest. The tension lies in defining what constitutes reasonable fees and acceptable business practices, raising concerns from some stakeholders who fear that stringent regulations might inadvertently lead to the consolidation of PBM power rather than promoting consumer choice and cost savings.

Companion Bills

No companion bills found.

Previously Filed As

US HB2214

DRUG Act Delinking Revenue from Unfair Gouging Act

US SB1542

DRUG Act Delinking Revenue from Unfair Gouging Act

US SB3245

Ensuring Accurate Payments to Specialty Pharmacies Act

US HB6030

Expanding Health Care Options for First Responders Act

US HB6358

Fair Warning Act of 2023

US HB6135

Stop Sexual Harassment in K–12 Act

US HB6114

Maximum Pressure Act

US SB4773

Universal School Meals Program Act of 2024 CHANGE Act Correcting Hurtful and Alienating Names in Government Expression Act Immigrants’ Mental Health Act of 2024 Menstrual Equity For All Act of 2024 Real Education and Access for Healthy Youth Act of 2024 Data To Save Moms Act CARE for Moms Act Community Access, Resources, and Empowerment for Moms Act Senior Hunger Prevention Act of 2024

US SB3330

A bill to require the Secretary of Labor to conduct a study on the fiduciary duties of pharmacy benefit managers.

US HB6131

Commercial Space Act of 2023

Similar Bills

US SB3245

Ensuring Accurate Payments to Specialty Pharmacies Act

US SB1542

DRUG Act Delinking Revenue from Unfair Gouging Act

US HB2214

DRUG Act Delinking Revenue from Unfair Gouging Act

US HB4317

PBM Reform Act of 2025 Pharmacy Benefit Manager Reform Act of 2025

US SB882

Patients Before Middlemen Act

US HB4011

TACT Act of 2023 Timely Access to Clinical Treatment Act of 2023

OR HB3212

Relating to pharmacy benefits.

US SB1339

Pharmacy Benefit Manager Reform Act